期刊文献+

转移瘤CD34及微血管表达的研究 被引量:9

CD34 Expression in Microvessels in Metastatic Carcinoma
下载PDF
导出
摘要 目的:探讨CD34在转移癌微血管中的表达。方法对43例转移癌组织标本(转移癌组)及11例舌鳞癌癌组织标本(鳞癌组)采用免疫组织化学SP法进行CD34染色;采用Weidner法计算CD34标记的肿瘤组织微血管密度(MVD)。结果应用显微照相系统计数转移癌组标本微血管数目为2~6根,鳞癌组标本的微血管数目为14~19根,转移癌组CD34的表达明显低于鳞癌组(P<0.01)。血管标记物标记的癌组织MVD值在男、女患者之间及在不同的转移瘤之间比较差异均无统计学意义(均P>0.05)。结论 CD34是理想的血管内皮细胞标记物,转移瘤血管生成较原发肿瘤明显减少,与原发肿瘤血管生成有明显差异。 Objective To explore the expression of CD34 in microvessels in metastatic carcinoma. Methods The expression of CD34 was determined using immunohistochemical SP method in 43 metastatic carcinoma specimens (metastatic carcinoma group)and 11 tongue squamous cell carcinoma specimens (squamous carcinoma group).The microvascular density (MVD)in CD34-labeled carcinoma specimens were calculated using Weidner method. Results Micrograph counting analysis showed 2-6 microvessels in metastatic carcinoma specimen and 14-19 microvessels in tongue squamous cell carcinoma specimen. The expression of CD34 in metastatic carcinoma group was significantly lower than that in squamous carcinoma group (P〈0.01).The difference in the MVD was not significant between male and female patients,as well as among different metastatic carcinomas(P〉0.05). Conclusion CD34 is an ideal vascular endothelial cell marker. Compared with primary tumors,the angiogenesis obviously decreased in metastatic carcinomas.
出处 《实用临床医学(江西)》 CAS 2014年第6期33-35,F0004,共4页 Practical Clinical Medicine
关键词 转移癌 血管生成 微血管密度 metastatic carcinoma angiogenesis microvascular density
  • 相关文献

参考文献16

  • 1Hasan J,Shnyder S D,Bibby M,et al.Quantitative angio- genesis assays in vivo-a review[J]. Angiogenesis,2004,7 (1):1-16.
  • 2Shivakumar S, Prabhakar B T,Jayashree K, et al.Evalua- tion of serum vascular endothelial growth factor (VEGF) and microvessel density(MVD)as prognostic indicators in carcinoma breast[J]. J Cancer Res Clin Oncol,2009,135,(4):627-636.
  • 3Benckert C,Thelen A,Cramer T,et al.lmpact of microvessel density on lymph node metastasis and survival after cura- tive resection of pancreatic caneer[J ].Surgery Today, 2012, 42(2):169-176.
  • 4Hansen T F, Sorensen F B, Spindler K L,et al.Mierovessel density and the association with single nucleotide poly- morphisms of the vascular endothelial growth factor re- ceptor 2 in patients with colorectal cancer [J].Virchows Archiv,2010,456(3):251-260.
  • 5Weidner N,Semple J P,Welch W R,et al.Tumor angiogen- esis and metastasis- correlation in invasive breast carci- noma[J].N Engl J Med,1991,324(1 ):1-8.
  • 6Ferrara N,Gerber H P,Couter J.The biology of VEGF and its reeeptors[J].Nat Med,2003,9(6):669-676.
  • 7Nesbit M.Abrogation of tumor vasculature using gene therapy[J].Cancer Metastasis Rev,2000,19 (1/2):45-49.
  • 8Folkman J.Role of angiogensis in tumor growth and metastasis [J].Semin Oncol,2002,29(6 S16):15-18.
  • 9Nyberg P,Xie L, Kalluri R.End0genous inhibitors of angio- gensis [J ].Cancer Res,2005,65 (10) :3967-3979.
  • 10薛妍,毕锋,刘文超,潘阳林,韩者艺,刘娜,刘长江,申慧琴,张学庸.缺氧状况下Rho GTPases的表达和活性变化及其与肿瘤血管生成关系的研究[J].中华肿瘤杂志,2004,26(9):517-520. 被引量:11

二级参考文献15

  • 1Fukuda R, Hirota K, Fan F, et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J
  • 2Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev, 1998,12:149-162.
  • 3Zhong H, Chiles K, Feldser D, et al. Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and thera
  • 4Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature, 2001,409:860-921.
  • 5Qiu RG, Chen J, McCormick F, et al. A role for Rho in Ras transformation. Proc Natl Acad Sci U S A, 1995,92:11781-11785.
  • 6Clark EA, Golub TR, Lander ES, et al. Genomic analysis of metastasis reveals an essential role for RhoC. Nature, 2000,406:532-535.
  • 7Ridley AJ. Rho GTPases and cell migration. J Cell Sci, 2001,114:2713-2722.
  • 8Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev, 1999,13:1501-1512.
  • 9Robles AI, Rodriguez-Puebla ML, Glick AB, et al. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev, 1998,12:2469-2474.
  • 10Pervaiz S, Cao J, Chao OS, et al. Activation of the RacGTPase inhibits apoptosis in human tumor cells. Oncogene, 2001,20:6263-6268.

共引文献10

同被引文献79

  • 1王守安,白人驹,孙浩然,征锦.肝转移瘤的CT灌注成像[J].实用放射学杂志,2007,23(9):1193-1197. 被引量:20
  • 2Lin G, Hagerstrand I, Lunderquist A. Portal blood supply of liver metastases [J ]. AJR Am J Roentgenol, 1984, 143 ( 1 ) : 53-55.
  • 3Joo I, Lee JM, Kim KW, et al. Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans evaluation of the hemodynamic features and correlation with the chemotherapy response[J].Eur J Radio, 2011,80 (3) : e278- 283.
  • 4Liu Y, Matsui O. Changes of intratumoral microvessels and blood perusion during establishment of hepatic metastases in mice[J].Radiology, 200?, 243(2) : 386- 395.
  • 5Benckert C,Thelen A,Cramer T,et al.Impact of microvessel density on lymph node metastasis and survival after curative resection of pancreatic cancer[J]. Surg Today, 2012,42 (2) ; 169-176.
  • 6Hansen TF, Sorensen FB, Spindler KL, et al. Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer[J]. Virchows Arch,2010,456(3) :251-260.
  • 7Miyata Y, Sagara Y, Watanabe S, et al. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34 [J]. Virchows Arch,2013,463(5) :673-679.
  • 8Miles KA,Leggett DA,Kelley BB,et al.In vivo assessment ofneovascularizaton of liver metastases using perfusion CT [J]. Br J Radiol,1998,71(843) :276-281.
  • 9范晴敏,陆正华.肝转移癌的微创治疗[J/CD].中华临床医师杂志:电子版,2013,7(6):2635-2637.
  • 10Wang DS, Louie JD, Sze DY. Intra-arterial therapies for metastatic colorectal cancer[J]. Semin Intervent Radiol, 2013,30(1) :12-20.

引证文献9

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部